Lv5
1276 积分 2022-04-14 加入
Evaluating the efficacy and safety of nivolumab and ipilimumab combination therapy compared to nivolumab monotherapy in advanced cancers (excluding melanoma): a systemic review and meta-analysis
8小时前
已完结
Cardiotoxicity associated with immune checkpoint inhibitors: Systematic Review and Meta-analysis
8小时前
已完结
Is nivolumab alone or in combination with ipilimumab more effective for treating lung cancer? a meta-analysis
8小时前
已完结
Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial
8小时前
已完结
Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1–2, open-label, multicohort trial
9小时前
已完结
Efficacy and Safety of Nivolumab Plus Ipilimumab vs Nivolumab Alone for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
9小时前
已完结
Neoadjuvant Dual Checkpoint Inhibitors vs Anti-PD1 Therapy in High-Risk Resectable Melanoma
9小时前
已完结
Comment on Elk et al. (2024) ‘Effects and implementation of an intervention to improve sleep, fatigue and recovery among healthcare workers with night shifts: A pre- and post-test study’
10天前
已完结
Effects of behavioural activation on psychological distress among people with cancer: A systematic review and meta-analysis
10天前
已完结
Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial
17天前
已完结
皖公网安备34019202002308
